Top Five Moments of 2021 at Tact.ai
2021 was a year of change, transformation, and inspiration. As Dr. Bertice Berry said, “When you walk with purpose, you collide with destiny.”
At Tact.ai, we had many moments this year that defined our path towards helping life science organizations think about the future of working with customers and creating better experiences.
As we approach 2022, here are five of our favorite moments from this past year.
Expanding the Tact.ai Team
In 2021, Tact.ai added talent across sales, product, marketing, and management from companies like IQVIA, Symphony Health, Veeva, ZS Associates, Takeda, and more.
Continuing our history of delivering innovative solutions to the market, Tact helped pharmaceutical, medical device, biotech, and others improve HCP (Health Care Professional) engagement and capture more data and preferences.
We welcomed amazing Humans of Tact like Sandeep, Gaurav, Kristin, Jeff, Laura, Craig, and industry veteran David Logue joined us as our new SVP & GM of Life Sciences and more. This reflects the growing interest of life science veterans believing the change in the industry was needed, joining our mission to help life sciences nurture more meaningful engagement with customers.
Named to CB Insight’s Coveted AI 100 List of Most Innovative Artificial Intelligence Startups
CB Insights named Tact.ai to the fifth annual AI (Artificial Intelligence) 100 ranking, showcasing the 100 most promising private artificial intelligence companies in the world.
Through an evidence-based approach, the CB Insights research team selected the AI 100 from a pool of over 6,000 companies based on several factors including patent activity, investor quality, competitive landscape, team strength, and tech novelty. We were one of only five companies selected in the cross-industry Sales and CRM category.
We celebrated Tact India Third Anniversary
Another important milestone we celebrated was the third anniversary of the Tact India office. This year saw a great mix of hybrid collaboration as both virtual and in-person events were filled with enthusiasm.
Along with successful celebrations in India, the Tact community, globally raised funds for India’s Oxygen Donation Drive in association with GiveIndia during the second COVID-19 wave.
We focused on Personalization in Medical Affairs at the Next Pharma Summit
Our SVP and GM of Life Sciences David Logue and Alasdair Stewart from Novartis hosted a session on "Medical Customer Engagement - the role of Digital and AI in personalizing each interaction, at scale" at the NEXT Normal event of NEXT Pharma Summit.
They examined the ongoing shift towards omnichannel customer engagement, how it impacts Medical Affairs, and why it matters to achieve personalization.
Life Science and Healthcare Leaders Bet on Tact.ai
We raised a new round of funding that included investments from Novartis (dRx Capital), Lilly, and McKesson Ventures. Existing investors including Microsoft’s M12 and Salesforce Ventures also participated in the round, bringing the company’s total funding to $88 million.
These investments highlighted the ever-growing demand for hybrid engagement in the life sciences industry, and how Tact’s technology helps them to work more effectively with healthcare professionals (HCPs).
As Rana Lonnen, Managing Director at dRx Capital, the Novartis Data and Digital Health Venture Fund quoted "Our Commercial and Medical teams at Novartis have been collaborating with Tact over the last two years to transform our field force and customer experience globally. Tact.ai aligns with our ambition to reimagine customer engagement for the New Normal."
As the year comes to a wrap, we wanted to take a moment to appreciate and thank our readers for being a part of our journey!
READ MORE LIKE THIS
The Future of HCP Engagement: Asynchronous and Omnichannel
As Pharma companies start rethinking the future of HCP engagement, the Tact.ai and BASE life science partnership is bringing these best practices forward to not only solve the...